Ubiquiti Inc. — Form 10-Q Summary
Period clarification: The filing covers the quarter and nine months ended March 31, 2024 (Ubiquiti fiscal 2024 Q3), not 2023 Q3. Unless otherwise noted, amounts are in U.S. dollars.
Business context and reporting period
Ubiquiti develops networking technology for service providers, enterprises and consumers. It reports as one operating segment, with revenue primarily from hardware sales and related implied post-contract support. Enterprise Technology generated 84% of Q3 revenue; Service Provider Technology generated 16%.
Financial performance and liquidity
| Metric | Q3 FY2024 | Q3 FY2023 | Nine months FY2024 | Nine months FY2023 |
|---|---|---|---|---|
| Revenue | $493.0M | $457.8M | $1,421.0M | $1,449.4M |
| Gross profit / margin | $174.1M / 35.3% | $188.5M / 41.2% | $535.6M / 37.7% | $557.4M / 38.5% |
| Operating income / margin | $111.2M / 22% | $133.5M / 29% | $360.6M / 26% | $400.7M / 28% |
| Net income | $76.3M | $98.6M | $246.2M | $304.0M |
| Diluted EPS | $1.26 | $1.63 | $4.07 | $5.03 |
- Cash flow: Nine-month operating cash flow was $310.1M, versus cash used of $159.9M in the prior-year period. Investing outflow was $10.1M, primarily capital expenditures. Financing outflow was $312.3M, including $203.1M of facility repayments and $108.8M of dividends. Cash declined $12.3M to $102.5M.
- Balance sheet and liquidity: Cash was $102.5M; current assets were $1,000.8M and current liabilities $253.5M at March 31, 2024. Inventory was $533.5M, down from $737.1M at June 30, 2023. Vendor deposits were $150.2M.
- Debt: Principal outstanding was $877.5M: $662.5M under term loans and $215.0M under the revolving facility. The balance-sheet carrying amount was $875.5M, net of debt issuance costs. Revolver availability was $485.0M; facilities mature March 30, 2026.
- Dividends: The company paid $0.60 per share each quarter during the nine-month period and declared a further $0.60 per share dividend payable May 28, 2024.
Material changes versus the prior comparable period
- Q3 revenue grew 8% year over year, driven primarily by Enterprise Technology, up 11% to $414.3M; Service Provider Technology revenue fell 7% to $78.7M. For the nine months, revenue declined 2%, with Enterprise down 3% and Service Provider up 1%.
- Q3 gross margin fell to 35.3% from 41.2%; the nine-month margin declined to 37.7% from 38.5%. Management cited excess and obsolete inventory charges and unfavorable product mix; higher Q3 shipping costs also weighed on margin, partly offset by lower tariffs.
- Q3 net income fell 23% year over year; nine-month net income fell 19%. Higher operating expenses and interest expense contributed. Nine-month interest expense and other, net rose to $58.4M from $38.4M, primarily due to higher interest rates.
- Nine-month cash generation improved substantially from the prior-year period, when a $489.5M inventory build contributed to operating cash outflow. Inventory declined during FY2024, while the company recorded $21.7M of inventory-obsolescence provision versus $8.1M previously.
Outlook, risks, contingencies and unusual items
- Outlook: No specific revenue, earnings or margin guidance is provided. Management says existing cash, operating cash flow and revolver availability should meet near-term needs, including working capital, dividends and capital expenditures, but notes this depends on assumptions and could change.
- Supply chain and inventory: Management reports limited visibility into future sales and ongoing exposure to supply constraints, component costs, shipping, excess or obsolete inventory and vendor-deposit losses. Nine-month vendor-deposit loss provision was $16.7M, compared with a $2.4M reversal in the prior-year period. Purchase commitments to manufacturers and suppliers totaled $949.5M; cancellations could still leave the company liable for component costs.
- Tax matters: The IRS dispute over FY2015–FY2016 could result in an estimated incremental tax liability of about $50M, excluding interest and penalties; no reserve was recorded. Hong Kong tax audits concern 2010–2018; $60.2M of deposits are recorded as an asset and management expects a refund, but an adverse outcome could be material. Unrecognized tax benefits were $35.9M, with $5.0M accrued interest. The transition-tax obligation was $50.6M.
- Legal matters: Patent litigation by Vivato/XR, Network-1 and Intellectual Ventures is ongoing. The company says it cannot estimate possible losses in these cases and intends to defend itself. It reported no pending or threatened litigation known to have a material adverse effect on the financial statements.
- Debt and market risks: Borrowings carry variable rates. A sustained 200-basis-point increase in rates would, absent mitigating action, add approximately $17.6M to pretax expense over the next 12 months. Credit facilities require maximum leverage and minimum interest-coverage ratios of 3.50:1.00.
- Other exposures: U.S. tariffs of 7.5%–25% on most China-origin products continue to affect margins. The filing also highlights geopolitical and supply-chain risks involving China, Taiwan, Russia and Ukraine, distributor concentration, cybersecurity, product defects and intellectual-property claims.
- Controls: Management concluded disclosure controls were effective as of March 31, 2024, with no material change in internal control over financial reporting during the quarter.
Important facts for investors to verify
- Confirm the reporting period: this is fiscal Q3 2024, ended March 31, 2024.
- Track whether revenue growth continues and whether gross margin recovers from the Q3 decline, particularly as inventory charges and product mix change.
- Monitor inventory, vendor deposits and the $949.5M of purchase commitments for further write-downs, losses or cash-flow effects.
- Assess debt repayment, variable-rate exposure, facility covenant headroom and the March 2026 maturity against cash generation and dividend payments.
- Follow developments in the IRS and Hong Kong tax matters and the three patent disputes; potential losses are not clearly quantified by the filing.
- Note that dividends remain subject to future board approval and that management provides no quantified operating guidance.